Clinical Trials in North Carolina

Showing 7641-7660 of 20,428 trials

DeepView SnapShot Portable (DV-SSP): Device Training Study

NCT05023135

The purpose of this study is to continue development and validation of an algorithm for burn healing assessment by the Spectral MD DeepView device and provide burn healing potential assessment.

BurnsWound Heal

SpectralMD251 participantsStarted Sep 2021

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Bridgeport, Connecticut, United States +8 more locations

COMPLETEDPhase 365 miles

A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Participants With Relapsing Multiple Sclerosis

NCT01412333

This randomized, double-blind, double-dummy, parallel-group study will evaluate the efficacy and safety of ocrelizumab in comparison with interferon beta-1a (Rebif) in participants with relapsing multiple sclerosis. Participants will be randomized to receive either ocrelizumab 600 mg or matching placebo intravenous (IV) as 300 mg infusions on Days 1 and 15 for the first dose and as a single infusion of 600 mg for all subsequent infusions every 24 weeks, with placebo injections matching interferon beta-1a SC three times per week; or interferon beta-1a 44 mcg SC injections three times per week (with placebo infusions matching ocrelizumab infusions every 24 weeks).

Relapsing Multiple Sclerosis

Hoffmann-La Roche835 participantsStarted Sep 2011

Phoenix, Arizona, United States • Scottsdale, Arizona, United States • Tucson, Arizona, United States +162 more locations

DeepView SnapShot Portable (DV-SSP): Device Training Study

A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Participants With Relapsing Multiple Sclerosis

Find Trials by Condition in North Carolina

Long-term Access Program (LAP) of Mepolizumab for Subjects Who Participated in Study MEA115921

Assess the Potential for Adrenal Suppression and Systemic Drug Absorption Following Multiple Dosing With DFD-06

A Comparison of DFD01 Spray Versus Vehicle Spray in Subjects With Moderate Psoriasis

On-X Heart Valve - 17mm Aortic and 23mm Mitral

Perceval Sutureless Implant Versus Standard-Aortic Valve Replacement

Study to Assess the Efficacy and Safety of Emapalumab in Primary Haemophagocytic Lymphohistiocytosis

Multi-center Phase I/IIa Trial of an Autologous Tumor Lysate (TL) + Yeast Cell Wall Particles (YCWP) + Dendritic Cells (DC) Vaccine in Addition to Standard of Care Checkpoint Inhibitor of Choice in Metastatic Melanoma Patients With Measurable Disease.

A Safety and Tolerability Study of NC318 in Subjects With Advanced or Metastatic Solid Tumors

Robotic-assisted and Laparoscopic Right Colectomy Study - Intracorporeal vs. Extracorporeal Anastomoses

Training Programs to Improve Outcomes for Individuals With Spinal Cord Injury

Prospective SPINE Registry

A Study of JNJ-73763989, Pegylated Interferon Alpha-2a and Nucleos(t)Ide Analogs in Participants With Chronic Hepatitis B Virus Infection

DFD01 Spray HPA Axis Suppression Study in Adolescent Patients With Moderate to Severe Plaque Psoriasis

Epithelioid Sarcoma Natural History Study

Control-IQ Technology in Individuals With Type 2 Diabetes

A Study on Patients With Chronic Kidney Disease (CKD) to Assess Treatment Experience and Patterns, Effect of the Treatment, Patient Outcomes and Patient Quality of Life

Platform Sub-study of Belantamab Mafodotin (GSK2857916) in Combination With aOX40 (GSK3174998) in Participants With RRMM

DCBY02 as a Monotherapy in Patients With Advanced or Metastatic Solid Tumors